XML 129 R72.htm IDEA: XBRL DOCUMENT v3.20.1
ACQUISITIONS AND OTHER ARRANGEMENTS - Claris Injectables Limited Narrative (Details) - USD ($)
$ in Millions
1 Months Ended 3 Months Ended 6 Months Ended 12 Months Ended
Jul. 27, 2017
Feb. 22, 2018
Dec. 31, 2019
Sep. 30, 2019
Jun. 30, 2019
Mar. 31, 2019
Dec. 31, 2018
Sep. 30, 2018
Jun. 30, 2018
Mar. 31, 2018
Jun. 30, 2019
Jun. 30, 2018
Dec. 31, 2019
Dec. 31, 2018
Dec. 31, 2017
Acquisitions And Collaborations [Line Items]                              
Total cash consideration, net of cash acquired           $ 109       $ 219 $ 111 $ 228 $ 418 $ 268 $ 686
Net sales     $ 3,039 $ 2,851 $ 2,834 $ 2,638 $ 2,833 $ 2,761 $ 2,813 $ 2,692 $ 5,472 $ 5,505 11,362 11,099 10,584
Claris Injectables Limited [Member]                              
Acquisitions And Collaborations [Line Items]                              
Percentage of ownership acquired 100.00%                            
Total cash consideration, net of cash acquired $ 629                            
Measurement period adjustments, reduction in property, plant and equipment               2              
Measurement period adjustments, increase in accounts payable and accrued liabilities               1              
Measurement period adjustments, increase in other long-term liabilities               2              
Measurement period adjustments, increase (decrease) in goodwill               $ 5              
Net sales                           140 57
Other intangible assets 280                            
Business acquisition settlement claims received   $ 73                          
Accrued liabilities released   $ 7                          
Business acquisition benefit of settlement claims and accrued liabilities released                         (80)    
Claris Injectables Limited [Member] | IPR&D                              
Acquisitions And Collaborations [Line Items]                              
Amount allocated from total consideration to acquire in-process research and development with indefinite useful life $ 140                            
Claris Injectables Limited [Member] | IPR&D | Measurement Input Discount Rate                              
Acquisitions And Collaborations [Line Items]                              
Discount rate used to measure intangible assets 0.130                            
Claris Injectables Limited [Member] | Developed Technology Rights                              
Acquisitions And Collaborations [Line Items]                              
Other intangible assets $ 140                            
Acquired intangible assets, weighted-average useful life 8 years                            
Claris Injectables Limited [Member] | Developed Technology Rights | Measurement Input Discount Rate                              
Acquisitions And Collaborations [Line Items]                              
Discount rate used to measure intangible assets 0.120                            
Claris Injectables Limited [Member] | Marketing and Administrative Expenses                              
Acquisitions And Collaborations [Line Items]                              
Integration costs                         $ 27 $ 33 $ 28